PATENT CLAIM ANALYSIS

Application Number: 15746254
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["540", "001000"]

Abstract:
Disclosed area fused ring pyrimidine compound, and an intermediate, a preparation method, a composition and a use thereof. The fused ring pyrimidine compound is a compound as shown in formula I, a tautomer, an enantiomer, a diastereoisomer, a pharmaceutically acceptable salt, a metabolite, a metabolic precursor or a prodrug thereof, wherein the above-mentioned compound is used for the preparation of a medicine for preventing, remitting or treating one or more of immune system diseases, autoimmune diseases, cell proliferative diseases, allergic disorders and cardiovascular diseases, and the compound has a strong inhibitory effect on the Janues kinase, FGFR kinase, FLT3 kinase and Src family kinase.

Claim (Index 13):
The compound according to  claim 12 , wherein, the compound of formula II is selected from the group consisting of the compound of formula III is selected from the group consisting of the compound of formula IV is selected from the group consisting of

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.83582
- Patent Class: 540.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14391386', '15025618', '15559181', '15568999', '15314938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747227415170973
- 35 USC 102 Novelty (BERT): 0.5304757733990557
- Combined Prediction Score: 0.7502980447052932
- Mean Citation Score: 330.97676
- Max Citation Score: 348.54816
- Similarity Product: 226.6117236281204

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test